Founded in 2004, DIURNAL®, a NEUROCRINE BIOSCIENCES® Company, is a European, UK-headquartered specialty pharmaceutical company dedicated to developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency.
Our expertise and innovative research activities focus on circadian-based endocrinology (mimicking the body's natural hormone levels) to develop products for rare and chronic endocrine conditions
This section is a resource providing information on Diurnal medicines available in the UK. It is not intended to replace the advice of a qualified doctor.
Diurnal is committed to transparency in its interactions. Diurnal commits to following the Association of British Pharmaceutical Industry (ABPI) Code of Practice which has clear requirements for transparency.
Diurnal is a rapidly growing global specialty pharmaceutical company with a highly integrated and very committed team. We're always looking for talented individuals who share our vision. Visit this section to view our current opportunities.
Diurnal is a rapidly growing global specialty pharmaceutical company with a highly integrated and very committed team.
We offer great flexibility and autonomy to our team members. Nobody in Diurnal gets lost in a large faceless department or function, and we have the satisfaction of working on innovative products that could be of benefit to patients suffering from debilitating endocrine diseases.
Interested? To view our current vacancies please click here.